Certificate By Practicing Company Secretary For Compliance Of Provisions Of Regulation 40(9) & 40(10) Of SEBI (LODR) Regulations, 2015.
We are furnishing herewith Compliance Certificate dated 10-04-2017 issued by Mr. V. Suresh, Practising Company Secretary, pursuant to the provisions of Regulation 40 (9) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half-year ended March 31, 2017. Please take the same on record. Shareholding for the Period Ended March 31, 2017
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended March 31, 2017.
Please find below statement of investor complaints for the quarter ended March 31, 2017. Status of complaints during the QuarterNo. of Complaints 1No. of complaints pending at the beginning of the quarterNil 2No. of complaints received during the quarterNil 3No. of complaints resolved during the quarterNil 4No. of complaints pending at the end of the quarterNil This statement is furnished pursuant to Regulation 13 (3) of the... Analyst Meet - Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mr. Mahesh Natarajan of ICICI Securities, accompanied by Mr. Shriraam Rathi, ISec Healthcare Research Analyst, would be having a one-to-one meeting with our CMD, Dr. A. Velumani on Monday, 10-04-2017 by 9.30 a.m. at our office. ii.Analysts from Falcon Edge, Comgest, Goldman Sachs, PineBridge, East Bridge and a few other Investors, would be having a one-to-one meeting with our CMD, Dr. A. Velumani on Monday, April 10, 2017 by 11.00 a.m., at... Analyst Meet
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Anmol Ganjoo, of J M Financial, would be having a meeting with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, by 10.00 A.M. Mr. Anmol Ganjoo might be accompanied by one or more of his colleague(s), or there could be a last minute change in the timing... Analyst Meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Abhishek Thepade, Fund Manager, of DNB Nor, would be having a meeting with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Wednesday, March 29, 2017 by 10.00 A.M. Mr. Abhishek Thepade might be accompanied by one or more of his colleague(s), or there could be a last... Outcome of Board Meeting
Our Board decided on reappointment of Dr.A.Velumani as MD & CEO for 3 years who chose to accept salary of Re.1 only p.m.and Mr. A. Sundararaju as ED & CFO for 3 years from 01-04-2017 who chose to accept same salary of Re.5 lakhs p.m, (2) also to acquire trademark Whaters - and NHL, the subsidiary to acquire trademark Nueclear from Dr. A.Velumani who chose to assign it for token consideration Re.1/- instead of Rs.1 crore each approved by the Boards earlier, and (3)to give loans to NHL. Analysts Meet
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Rahul Gupta, Investment Analyst, of Fidelity International, would be having a meeting with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Thursday, March 23, 2017 by 10.30 A.M. Mr. Rahul Gupta might be accompanied by one or more of his colleague(s), or there could... Conference Call - Change In Timing.
Please refer to the announcement made by us yesterday that Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse would be having a conference call with our General Manager- Finance, Mr. Sachin Salvi, today by 11.00 A.M. Please note that Credit Suisse has re-scheduled the call to take place by 3.30 p.m. today and some other analysts/investors might also be participating in the conference call. Please note that no price-sensitive information will be shared during the call. Conference Call With Analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse would be having a conference call with our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 by 11.00 A.M. One or more of his colleagues might be joining Mr. Anubhav Aggarwal in the Conference Call. Please note that no price-sensitive information will be shared during the call.